Piotr Kuna Selected Research

Piotr Kuna Research Topics

Disease

129	Asthma (Bronchial Asthma) 05/2024 - 01/2002
36	Inflammation (Inflammations) 08/2023 - 01/2002
31	Hypersensitivity (Allergy) 01/2023 - 03/2002
22	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 01/2002
14	Allergic Rhinitis 01/2024 - 01/2009
8	COVID-19 01/2023 - 01/2020
7	Urticaria (Hives) 01/2024 - 01/2012
7	Seasonal Allergic Rhinitis (Hay Fever) 03/2022 - 01/2002
7	Bronchial Hyperreactivity 01/2022 - 01/2002
6	Rhinitis 01/2024 - 01/2019
6	Rhinosinusitis 11/2023 - 01/2016
6	Nasal Polyps (Nasal Polyp) 11/2023 - 03/2004
5	Disease Progression 04/2024 - 02/2002
5	Chronic Urticaria 01/2024 - 07/2013
5	Atopic Dermatitis (Atopic Eczema) 11/2023 - 05/2005
5	Eosinophilia 01/2018 - 01/2006
4	Lung Diseases (Lung Disease) 08/2023 - 04/2012
4	Respiratory Tract Diseases (Respiratory Tract Disease) 07/2023 - 01/2014
4	Infections 01/2023 - 05/2006
4	Anaphylaxis (Anaphylactic Shock) 01/2023 - 10/2019
4	Neoplasms (Cancer) 01/2023 - 12/2005
3	Obstructive Lung Diseases (Obstructive Lung Disease) 08/2023 - 01/2019
3	Airway Remodeling 01/2020 - 01/2014
3	Pneumonia (Pneumonitis) 01/2019 - 07/2008
2	Fibrosis (Cirrhosis) 01/2022 - 07/2019
2	Hypoxia (Hypoxemia) 01/2020 - 08/2018

Drug/Important Bio-Agent (IBA)

38	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 06/2003
22	AllergensIBA 04/2024 - 02/2002
22	CytokinesIBA 01/2023 - 01/2002
18	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 02/2002
14	Immunoglobulin E (IgE)IBA 01/2023 - 03/2002
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2002
13	Monoclonal AntibodiesIBA 01/2023 - 01/2006
11	Interleukin-5 (Interleukin 5)IBA 01/2024 - 06/2003
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
11	Omalizumab (Xolair)FDA Link 04/2019 - 01/2009
10	Budesonide (Pulmicort)FDA LinkGeneric 02/2016 - 06/2003
9	SteroidsIBA 08/2023 - 08/2004
9	Interleukin-13IBA 01/2023 - 03/2002
9	montelukast (Singulair)FDA Link 02/2020 - 01/2002
9	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017 - 01/2010
8	Beclomethasone (Beclometasone)FDA Link 01/2022 - 08/2003
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2012
7	Fluticasone (Cutivate)FDA LinkGeneric 10/2022 - 08/2003
7	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2002
7	Messenger RNA (mRNA)IBA 01/2018 - 01/2013
6	InterleukinsIBA 01/2020 - 01/2007
6	Interleukin-4 (Interleukin 4)IBA 01/2020 - 02/2002
6	GlucocorticoidsIBA 01/2018 - 03/2002
6	LeukotrienesIBA 01/2008 - 01/2002
5	benralizumabIBA 07/2023 - 11/2014
5	TabletsIBA 03/2022 - 01/2009
5	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 01/2002
5	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2021 - 01/2010
5	Nedocromil (Alocril)FDA Link 08/2004 - 01/2002
5	Histamine (Histamine Dihydrochloride)FDA Link 08/2004 - 02/2002
4	bilastineIBA 01/2024 - 01/2012
4	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2012
4	tralokinumabIBA 01/2022 - 12/2015
4	EnzymesIBA 01/2021 - 06/2003
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2016 - 06/2003
4	Formoterol Fumarate Drug Combination Budesonide FDA Link 01/2010 - 06/2003
4	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 08/2004 - 01/2002
3	anti-IgE antibodiesIBA 12/2023 - 01/2022
3	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2006
3	Peroxidase (Myeloperoxidase)IBA 01/2020 - 01/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 06/2003
3	Tiotropium Bromide (Spiriva)FDA Link 11/2019 - 01/2015
3	Prostaglandin D2IBA 01/2019 - 08/2017
3	Interleukin-15 (Interleukin 15)IBA 11/2017 - 06/2016
3	Immunoglobulins (Immunoglobulin)IBA 04/2016 - 03/2002
3	Interleukin-12 (IL 12)IBA 01/2014 - 06/2003
3	ChemokinesIBA 10/2013 - 05/2005
3	desloratadine (Aerius)FDA LinkGeneric 01/2012 - 02/2005
2	SmokeIBA 08/2023 - 01/2019
2	mepolizumabIBA 07/2023 - 01/2020
2	dupilumabIBA 01/2023 - 01/2023
2	Peptides (Polypeptides)IBA 01/2023 - 01/2020
2	lebrikizumabIBA 07/2022 - 01/2022
2	AnkyrinsIBA 03/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 03/2004
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2014
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021 - 05/2015
2	Phospholipases A2 (Phospholipase A2)IBA 01/2021 - 01/2014
2	LipopolysaccharidesIBA 01/2021 - 01/2014
2	Immunoglobulin G (IgG)IBA 02/2020 - 04/2016
2	Platelet-Derived Growth FactorIBA 01/2020 - 08/2018
2	Dinoprostone (PGE2)FDA Link 01/2019 - 01/2008

Therapy/Procedure

37	Therapeutics 01/2023 - 01/2002
10	Immunotherapy 11/2022 - 03/2002
8	Drug Therapy (Chemotherapy) 11/2022 - 10/2011
7	Nebulizers and Vaporizers (Inhaler) 01/2022 - 09/2006
7	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 09/2014
5	Biological Therapy 02/2024 - 04/2019
5	Dry Powder Inhalers 01/2021 - 08/2003
3	Aftercare (After-Treatment) 04/2016 - 01/2002
2	Injections 10/2021 - 02/2011
2	Drug Tapering 01/2021 - 08/2003